345 related articles for article (PubMed ID: 8976111)
21. Phosphoribosylpyrophosphate synthetase superactivity. A study of five patients with catalytic defects in the enzyme.
Becker MA; Losman MJ; Rosenberg AL; Mehlman I; Levinson DJ; Holmes EW
Arthritis Rheum; 1986 Jul; 29(7):880-8. PubMed ID: 3017368
[TBL] [Abstract][Full Text] [Related]
22. Point mutations in PRPS1, the gene encoding the PRPP synthetase (PRS) 1 isoform, underlie X-linked PRS superactivity associated with purine nucleotide inhibitor-resistance.
Becker MA; Nosal JM; Switzer RL; Smith PR; Palella TD; Roessler BJ
Adv Exp Med Biol; 1994; 370():707-10. PubMed ID: 7661003
[No Abstract] [Full Text] [Related]
23. Superactivity of human phosphoribosyl pyrophosphate synthetase due to altered regulation by nucleotide inhibitors and inorganic phosphate.
Becker MA; Losman MJ; Wilson J; Simmonds HA
Biochim Biophys Acta; 1986 Jun; 882(2):168-76. PubMed ID: 2423135
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic evaluation of phosphoribosylpyrophosphate synthetase activities in hemolysates.
Losman MJ; Hecker S; Woo S; Becker MA
J Lab Clin Med; 1984 Jun; 103(6):932-43. PubMed ID: 6327865
[TBL] [Abstract][Full Text] [Related]
25. [Phosphoribosylpyrophosphate(PRPP) synthetase].
Kawasugi K; Takeuchi F
Nihon Rinsho; 2003 Jan; 61 Suppl 1():20-3. PubMed ID: 12629685
[No Abstract] [Full Text] [Related]
26. PRPP and purine nucleotide metabolism in human lymphoblasts with both PRPP synthetase superactivity and HGPRT deficiency.
Becker MA; Kim M; Husain K
Adv Exp Med Biol; 1989; 253B():13-20. PubMed ID: 2481968
[No Abstract] [Full Text] [Related]
27. Increased purine nucleotide degradation in the central nervous system (CNS) in PRPP synthetase superactivity.
Jiménez ML; Puig JG; Mateos FA; Ramos TH; Melián JS; Nieto VG; Becker MA
Adv Exp Med Biol; 1989; 253A():9-13. PubMed ID: 2560341
[No Abstract] [Full Text] [Related]
28. Characterization of the phosphoribosylpyrophosphate synthetase gene from Candida albicans.
Payne T; Calderone R
J Med Vet Mycol; 1997; 35(5):305-12. PubMed ID: 9402522
[TBL] [Abstract][Full Text] [Related]
29. [5-Phosphoribosyl-1-pyrophosphate synthetase overexpression].
Kamatani N; Totokawa S
Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):432-4. PubMed ID: 9590092
[No Abstract] [Full Text] [Related]
30. Human phosphoribosylpyrophosphate synthetase: radioimmunochemical quantitation in erythrocytes and fibroblasts.
Itkin P; Woo S; Becker MA
J Lab Clin Med; 1984 Jul; 104(1):96-109. PubMed ID: 6330252
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of two enzyme genes, HPRT1 and PRPS1, causing X-linked inborn errors of purine metabolism.
Yamada Y; Yamada K; Nomura N; Yamano A; Kimura R; Tomida S; Naiki M; Wakamatsu N
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):291-4. PubMed ID: 20544509
[TBL] [Abstract][Full Text] [Related]
32. [PRPP synthetase deficiency].
Imaeda H; Wada Y
Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):435-7. PubMed ID: 9590093
[No Abstract] [Full Text] [Related]
33. Phosphoribosylpyrophosphate synthetase and the regulation of phosphoribosylpyrophosphate production in human cells.
Becker MA
Prog Nucleic Acid Res Mol Biol; 2001; 69():115-48. PubMed ID: 11550793
[TBL] [Abstract][Full Text] [Related]
34. Clinical manifestations and molecular aspects of phosphoribosylpyrophosphate synthetase superactivity in females.
Zikánová M; Wahezi D; Hay A; Stiburková B; Pitts C; Mušálková D; Škopová V; Barešová V; Soucková O; Hodanová K; Živná M; Stránecký V; Hartmannová H; Hnízda A; Bleyer AJ; Kmoch S
Rheumatology (Oxford); 2018 Jul; 57(7):1180-1185. PubMed ID: 30423175
[TBL] [Abstract][Full Text] [Related]
35. Kinetic aspects of purine metabolism in cultured fibroblasts. A comparative study of cells from patients overproducing purines due to HGPRT deficiency and PRPP synthetase superactivity.
Zoref E; de Vries A; Sperling O
Monogr Hum Genet; 1978; 10():96-9. PubMed ID: 214700
[No Abstract] [Full Text] [Related]
36. Overexpression of the normal phosphoribosylpyrophosphate synthetase 1 isoform underlies catalytic superactivity of human phosphoribosylpyrophosphate synthetase.
Becker MA; Taylor W; Smith PR; Ahmed M
J Biol Chem; 1996 Aug; 271(33):19894-9. PubMed ID: 8702702
[TBL] [Abstract][Full Text] [Related]
37. [Historical review of gout and hyperuricemia investigations].
Nakamura T
Nihon Rinsho; 2008 Apr; 66(4):624-35. PubMed ID: 18409506
[TBL] [Abstract][Full Text] [Related]
38. Selective expression of phosphoribosylpyrophosphate synthetase superactivity in human lymphoblast lines.
Losman MJ; Rimon D; Kim M; Becker MA
J Clin Invest; 1985 Oct; 76(4):1657-64. PubMed ID: 2414323
[TBL] [Abstract][Full Text] [Related]
39. Phosphoribosylpyrophosphate synthetase superactivity and recurrent infections is caused by a p.Val142Leu mutation in PRS-I.
Moran R; Kuilenburg AB; Duley J; Nabuurs SB; Retno-Fitri A; Christodoulou J; Roelofsen J; Yntema HG; Friedman NR; van Bokhoven H; de Brouwer AP
Am J Med Genet A; 2012 Feb; 158A(2):455-60. PubMed ID: 22246954
[TBL] [Abstract][Full Text] [Related]
40. [PRPP synthetase deficiency].
Kawasugi K; Takeuchi F
Nihon Rinsho; 2003 Jan; 61 Suppl 1():383-5. PubMed ID: 12629752
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
